Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H13N3O5S |
| Molecular Weight | 335.335 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(C(=O)NC2=NOC(C)=C2)=C(O)C3=CC=CC=C3S1(=O)=O
InChI
InChIKey=YYUAYBYLJSNDCX-UHFFFAOYSA-N
InChI=1S/C14H13N3O5S/c1-8-7-11(16-22-8)15-14(19)12-13(18)9-5-3-4-6-10(9)23(20,21)17(12)2/h3-7,18H,1-2H3,(H,15,16,19)
Isoxicam is a nonsteroidal anti-inflammatory drug with long half-life. The major oxidative excretion product of isoxicam is the hydroxymethlyisoxazole metabolite, minor metabolites are open-ring sulfonamide and N-methylsaccharin. Isoxicam Is effective and well tolerated in all the major rheumatic
diseases.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL53292
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
100000082858
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
C80558
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
m789
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB08942
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
758436
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
34552-84-6
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
252-084-5
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
DTXSID0045462
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
SUB08344MIG
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
54677972
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
Isoxicam
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
C013580
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
3435
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
1509
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
76163
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
8XU734C4NG
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
